- Home
- BLNK vs THTX Comparison
BLNK vs THTX Comparison
Compare BLNK & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- THTX
- Stock Information
- Founded
- BLNK 2009
- THTX 1993
- Country
- BLNK United States
- THTX Canada
- Employees
- BLNK N/A
- THTX N/A
- Industry
- BLNK Industrial Specialties
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- THTX Health Care
- Exchange
- BLNK Nasdaq
- THTX Nasdaq
- Market Cap
- BLNK 105.2M
- THTX 118.2M
- IPO Year
- BLNK N/A
- THTX N/A
- Fundamental
- Price
- BLNK $0.84
- THTX $2.62
- Analyst Decision
- BLNK Buy
- THTX Hold
- Analyst Count
- BLNK 8
- THTX 1
- Target Price
- BLNK $3.19
- THTX N/A
- AVG Volume (30 Days)
- BLNK 2.8M
- THTX 6.2M
- Earning Date
- BLNK 05-12-2025
- THTX 04-09-2025
- Dividend Yield
- BLNK N/A
- THTX N/A
- EPS Growth
- BLNK N/A
- THTX N/A
- EPS
- BLNK N/A
- THTX N/A
- Revenue
- BLNK $126,197,000.00
- THTX $88,666,000.00
- Revenue This Year
- BLNK $1.49
- THTX N/A
- Revenue Next Year
- BLNK $31.89
- THTX $15.13
- P/E Ratio
- BLNK N/A
- THTX N/A
- Revenue Growth
- BLNK N/A
- THTX 13.52
- 52 Week Low
- BLNK $0.63
- THTX $1.08
- 52 Week High
- BLNK $3.75
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- BLNK 56.46
- THTX 57.56
- Support Level
- BLNK $0.71
- THTX $2.64
- Resistance Level
- BLNK $0.77
- THTX $2.82
- Average True Range (ATR)
- BLNK 0.05
- THTX 0.17
- MACD
- BLNK 0.02
- THTX -0.04
- Stochastic Oscillator
- BLNK 81.34
- THTX 20.45
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.